CGTX Cognition Therapeutics, Inc. - Common Stock
$1,15
Prix · Mai 20, 2026
Données fondamentales au Mai 8, 2026
Fourchette 52 semaines
$0–$4
26% of range
Note des analystes
BUY
10 analysts
Objectif de cours
$4
+206% upside
P/E (TTM)
-4.2
ROE
-113.7%
Marge nette
—
CGTX Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$1.15
Capitalisation Boursière
$120M
P/E (TTM)
-4.2
BPA (TTM)
$-0.32
Revenus (TTM)
—
Rendement div.
—
ROE
-113.7%
Dette/Capitaux propres
—
Fourchette 52 semaines
$0 – $4
CGTX Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
—
BPA
$-0.32
2020-12-31
→
2025-12-31
Flux de trésorerie libre
—
2021-12-31
→
2024-12-31
Marges
—
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
CGTX
Médiane des pairs
P/E (TTM)
-4.2
22.6
P/S (TTM)
-4286.5
13.3
P/B
3.5
3.5
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
CGTX
Médiane des pairs
ROA
-59.8%
-62.6%
ROE
-113.7%
-59.0%
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
CGTX
Médiane des pairs
Current Ratio (Ratio de liquidité)
3.4
2.7
Quick Ratio (Ratio de liquidité réduite)
2.6
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
CGTX
Médiane des pairs
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
CGTX
Médiane des pairs
CGTX Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
10 analystes
- Achat fort 2 20,0%
- Achat 7 70,0%
- Conserver 1 10,0%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
4 analystes · 2026-05-16
Médiane
$3.50
← En dessous de tous les objectifs
$1.15
Bas
$3.00
Haut
$4.00
Objectif médian
$3.50
+205,7%
Objectif moyen
$3.50
+205,7%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.01%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.05 | $-0.07 | 0.02% |
| 31 décembre 2025 | $-0.05 | $-0.09 | 0.04% |
| 30 septembre 2025 | $-0.06 | $-0.10 | 0.04% |
| 30 juin 2025 | $-0.11 | $-0.11 | -0.00% |
| 31 mars 2025 | $-0.14 | $-0.11 | -0.03% |
| 31 décembre 2024 | $-0.17 | $-0.14 | -0.03% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| CGTX | $120M | -4.2 | — | — | -113.7% | — |
| RANI | — | -3.0 | 58.9% | -1817.1% | -169.6% | — |
| NRXP | — | — | — | — | — | — |
| VRCA | $143M | -4.9 | 370.2% | -50.3% | -492.8% | — |
| LONA | $71M | -0.3 | — | — | -353.4% | — |
| AARD | $286M | -4.5 | — | — | -47.3% | — |
| TELO | $46M | -4.0 | — | — | -325.7% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 12
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $37M | $42M | $37M | $30M | $19M | $13M | |
| SG&A Expense | $11M | $12M | $14M | $13M | $10M | $5M | |
| Operating Expenses | $48M | $54M | $51M | $44M | $29M | $17M | |
| Operating Income | $-48M | $-54M | $-51M | $-44M | $-29M | $-17M | |
| Other Non-op | $24M | $20M | $25M | $22M | $17M | $10M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-23M | $-34M | $-26M | $-21M | $-12M | $-8M | |
| EPS (Basic) | $-0.32 | $-0.86 | $-0.86 | $-0.91 | $-3.13 | $-23.76 | |
| EPS (Diluted) | $-0.32 | $-0.86 | $-0.86 | $-0.91 | $-3.13 | $-23.76 | |
| Shares (Basic) | 72,766,983 | 39,730,148 | 30,029,087 | 23,640,199 | 5,190,883 | 508,112 | |
| Shares (Diluted) | 72,766,983 | 39,730,148 | 30,029,087 | 23,640,199 | 5,190,883 | 508,112 | |
| EBITDA | $-48M | $-54M | $-51M | $-43M | $-29M | · |
Bilan 22
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37M | $25M | $30M | $42M | $55M | $5M | |
| Prepaid Expense | $1M | $2M | $3M | $2M | $2M | $544.0K | |
| Other Current Assets | · | · | · | · | $11.0K | $23.0K | |
| Current Assets | $48M | $30M | $34M | $48M | $59M | $7M | |
| PP&E (Net) | $93.0K | $181.0K | $284.0K | $233.0K | $145.0K | $211.0K | |
| PP&E (Gross) | $280.0K | $1M | $1M | $1M | $1M | $988.0K | |
| Accum. Depreciation | $187.0K | $1M | $1M | $953.0K | $870.0K | $777.0K | |
| Total Assets | $48M | $30M | $35M | $50M | $59M | $7M | |
| Accounts Payable | $1M | $2M | $4M | $3M | $4M | $2M | |
| Accrued Liabilities | $12M | $8M | $4M | $2M | $2M | $994.0K | |
| Current Liabilities | $14M | $11M | $10M | $8M | $8M | $3M | |
| Capital Leases | $195.0K | $342.0K | $520.0K | $695.0K | · | · | |
| Deferred Tax | $67.0K | $110.0K | $147.0K | $178.0K | $13.0K | $22.0K | |
| Other Non-current Liabilities | · | · | $0 | $2M | $0 | · | |
| Total Liabilities | $14M | $11M | $11M | $10M | $8M | $20M | |
| Common Stock | $90.0K | $60.0K | $32.0K | $29.0K | $22.0K | $1.0K | |
| Paid-in Capital | $233M | $194M | $166M | $156M | $145M | $222.0K | |
| Retained Earnings | $-199M | $-175M | $-141M | $-115M | $-94M | $-68M | |
| AOCI | · | · | $-195.0K | $-199.0K | $-198.0K | $-187.0K | |
| Stockholders' Equity | $34M | $19M | $24M | $40M | $51M | $-68M | |
| Liabilities + Equity | $48M | $30M | $35M | $50M | $59M | $7M | |
| Shares Outstanding | 88,904,161 | 59,854,877 | 32,165,478 | 28,991,548 | 22,230,032 | 538,793 |
Flux de trésorerie 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $36.0K | $107.0K | $96.0K | $83.0K | $93.0K | $98.0K | |
| Stock-based Comp | $2M | $4M | $4M | $4M | $5M | $475.0K | |
| Deferred Tax | · | $0 | $0 | $0 | · | · | |
| Other Non-cash | $-3M | $2M | $5M | $-791.0K | $3M | · | |
| Operating Cash Flow | $-25M | $-28M | $-16M | $-19M | $-4M | $-3M | |
| CapEx | · | $4.0K | $147.0K | $171.0K | $27.0K | $10.0K | |
| Investing Cash Flow | $9.0K | $-4.0K | $-147.0K | $-171.0K | $-27.0K | $-10.0K | |
| Financing Cash Flow | $37M | $24M | $5M | $6M | $53M | $6M | |
| Net Change in Cash | $12M | $-5M | $-12M | $-13M | $50M | $2M | |
| Free Cash Flow | · | $-28M | $-16M | $-19M | $-4M | · |
Rentabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | 187866.7% | 155539.3% | 3202.5% | · | |
| Net Margin | · | · | 95511.1% | 76417.9% | 1312.0% | · | |
| EBITDA Margin | · | · | 187511.1% | 155242.9% | 3192.1% | · | |
| ROA | -59.8% | -103.9% | -60.3% | -39.1% | -35.4% | · | |
| ROE | -113.7% | -204.5% | -96.6% | -53.8% | 66.1% | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 2.7 | 3.4 | 6.1 | 7.5 | · | |
| Quick Ratio | 2.6 | 2.2 | 2.9 | 5.3 | 7.0 | · |
Efficacité 1
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | -0.0 | -0.0 | -0.0 | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $-28.0K | $-28.0K | $-27.0K | $-28.0K | $-893.0K | · | |
| Net Income TTM | $-23M | $-34M | $-26M | $-21M | $-12M | · | |
| Market Cap | $120M | $42M | $60M | $61M | $140M | · | |
| P/E | -4.2 | -0.8 | -2.2 | -2.3 | -2.0 | · | |
| P/S | -4286.5 | -1498.5 | -2203.9 | -2174.4 | -157.3 | · | |
| P/B | 3.5 | 2.2 | 2.4 | 1.5 | 2.7 | · | |
| P / Tangible Book | 3.5 | 2.2 | 2.4 | 1.5 | 2.7 | · | |
| P / Cash Flow | -4.9 | -1.5 | -3.7 | -3.3 | -38.7 | · | |
| P / FCF | · | -1.5 | -3.7 | -3.3 | -38.4 | · | |
| Earnings Yield | -23.7% | -122.7% | -46.5% | -43.3% | -49.5% | · |
Compte de résultat 13
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $6M | $11M | $4M | $11M | $11M | $8M | $11M | $12M | $11M | $12M | $12M | $8M | $5M | $6M | $8M | $9M | |
| SG&A Expense | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $4M | $3M | $4M | $3M | |
| Operating Expenses | $9M | $14M | $6M | $14M | $14M | $11M | $14M | $15M | $14M | $15M | $15M | $12M | $9M | $9M | $13M | $12M | |
| Operating Income | $-9M | $-14M | $-6M | $-14M | $-14M | $-11M | $-14M | $-15M | $-14M | $-15M | $-15M | $-12M | $-9M | $-9M | $-13M | $-12M | |
| Other Non-op | $4M | $10M | $1M | $7M | $5M | $3M | $5M | $8M | $5M | $7M | $8M | $7M | $3M | $4M | $6M | $6M | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | $-5M | $-6M | · | · | $-6M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-125.0K | |
| Net Income | $-5M | $-3M | $-5M | $-7M | $-8M | $-8M | $-10M | $-7M | $-9M | $-8M | $-7M | $-5M | $-6M | $-5M | $-7M | $-6M | |
| EPS (Basic) | $-0.05 | $-0.01 | $-0.06 | $-0.11 | $-0.14 | $-0.16 | $-0.25 | $-0.18 | $-0.27 | $-0.27 | $-0.22 | $-0.16 | $-0.21 | $-0.20 | $-0.29 | $-0.25 | |
| EPS (Diluted) | $-0.05 | $-0.01 | $-0.06 | $-0.11 | $-0.14 | $-0.16 | $-0.25 | $-0.18 | $-0.27 | $-0.27 | $-0.22 | $-0.16 | $-0.21 | $-0.20 | $-0.29 | $-0.25 | |
| Shares (Basic) | 89,191,313 | -130,703,624 | 77,951,513 | 63,690,945 | 61,828,149 | -74,486,140 | 40,418,065 | 40,062,954 | 33,735,269 | -59,045,833 | 30,365,506 | 29,614,822 | 29,094,592 | -44,406,168 | 23,024,026 | 22,595,359 | |
| Shares (Diluted) | 89,191,313 | -130,703,624 | 77,951,513 | 63,690,945 | 61,828,149 | -74,486,140 | 40,418,065 | 40,062,954 | 33,735,269 | -59,045,833 | 30,365,506 | 29,614,822 | 29,094,592 | -44,406,168 | 23,024,026 | 22,595,359 | |
| EBITDA | $-9M | · | $-6M | $-14M | $-14M | · | $-14M | $-15M | $-14M | · | $-15M | $-12M | $-9M | · | $-13M | $-12M |
Bilan 21
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $31M | $37M | $39M | $11M | $16M | $25M | $22M | $29M | $35M | $30M | $33M | $37M | $39M | $42M | $47M | $46M | |
| Prepaid Expense | $932.0K | $1M | $1M | $1M | $2M | $2M | $1M | $2M | $2M | $3M | $1M | $2M | $2M | $2M | $2M | $2M | |
| Current Assets | $36M | $48M | $43M | $19M | $23M | $30M | $27M | $34M | $38M | $34M | $36M | $42M | $43M | $48M | $51M | $51M | |
| PP&E (Net) | $77.0K | $93.0K | $159.0K | $174.0K | $190.0K | $181.0K | $207.0K | $234.0K | $257.0K | $284.0K | $281.0K | $248.0K | $253.0K | $233.0K | $246.0K | $245.0K | |
| PP&E (Gross) | · | $280.0K | · | · | · | $1M | · | · | · | $1M | · | · | · | $1M | · | · | |
| Accum. Depreciation | · | $187.0K | · | · | · | $1M | · | · | · | $1M | · | · | · | $953.0K | · | · | |
| Total Assets | $36M | $48M | $43M | $20M | $24M | $30M | $28M | $34M | $39M | $35M | $39M | $44M | $46M | $50M | $54M | $53M | |
| Accounts Payable | $4M | $1M | $827.0K | $771.0K | $2M | $2M | $2M | $3M | $3M | $4M | $3M | $4M | $3M | $3M | $8M | $3M | |
| Accrued Liabilities | $2M | $12M | $4M | $9M | $8M | $8M | $10M | $6M | $5M | $4M | $4M | $2M | $2M | $2M | $2M | $2M | |
| Current Liabilities | $6M | $14M | $7M | $12M | $11M | $11M | $13M | $11M | $10M | $10M | $8M | $8M | $7M | $8M | $12M | $7M | |
| Capital Leases | $176.0K | $195.0K | $212.0K | $229.0K | $280.0K | $342.0K | $392.0K | $440.0K | $488.0K | $520.0K | $565.0K | $608.0K | $651.0K | $695.0K | $603.0K | $404.0K | |
| Deferred Tax | · | $67.0K | · | · | · | $110.0K | · | · | · | $147.0K | · | · | · | $178.0K | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | $0 | $0 | $0 | · | $1M | $1M | $2M | $2M | $2M | $2M | |
| Total Liabilities | $6M | $14M | $7M | $13M | $11M | $11M | $13M | $11M | $10M | $11M | $10M | $10M | $10M | $10M | $14M | $9M | |
| Common Stock | $90.0K | $90.0K | $88.0K | $65.0K | $62.0K | $60.0K | $41.0K | $40.0K | $40.0K | $32.0K | $30.0K | $30.0K | $29.0K | $29.0K | $24.0K | $22.0K | |
| Paid-in Capital | $233M | $233M | $232M | $197M | $196M | $194M | $182M | $180M | $179M | $166M | $162M | $161M | $158M | $156M | $150M | $148M | |
| Retained Earnings | $-203M | $-199M | $-195M | $-190M | $-184M | $-175M | $-167M | $-157M | $-150M | $-141M | $-133M | $-126M | $-122M | $-115M | $-110M | $-104M | |
| AOCI | · | · | · | · | · | · | · | · | · | $-195.0K | $-196.0K | $-196.0K | $-195.0K | $-199.0K | $-201.0K | $-200.0K | |
| Stockholders' Equity | $30M | $34M | $37M | $7M | $12M | $19M | $14M | $23M | $29M | $24M | $29M | $34M | $36M | $40M | $39M | $44M | |
| Liabilities + Equity | $36M | $48M | $43M | $20M | $24M | $30M | $28M | $34M | $39M | $35M | $39M | $44M | $46M | $50M | $54M | $53M | |
| Shares Outstanding | 89,353,773 | 88,904,161 | 88,268,078 | 64,962,957 | 61,974,755 | 59,854,877 | 40,806,092 | 40,112,268 | 39,985,866 | 32,165,478 | 30,417,082 | 30,286,582 | 29,277,227 | 28,991,548 | 23,969,497 | 22,597,907 |
Flux de trésorerie 11
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | $14.0K | $15.0K | · | · | $27.0K | $27.0K | $26.0K | $27.0K | $27.0K | $25.0K | $23.0K | $21.0K | $23.0K | $22.0K | $20.0K | |
| Stock-based Comp | $330.0K | $358.0K | $522.0K | $621.0K | $586.0K | $534.0K | $896.0K | $1M | $1M | $1M | $1M | $1M | $1M | $902.0K | $777.0K | $892.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | $709.0K | · | · | · | $2M | · | · | · | |
| Operating Cash Flow | $-6M | $-3M | $-6M | $-6M | $-10M | $-8M | $-7M | $-6M | $-7M | $-5M | $-4M | $-4M | $-3M | $-10M | $-4.0K | $-5M | |
| CapEx | · | · | · | · | · | $1.0K | $0 | · | · | $30.0K | $58.0K | $18.0K | $41.0K | $10.0K | $23.0K | $4.0K | |
| Investing Cash Flow | · | · | · | · | · | $-1.0K | $0 | · | · | $-30.0K | $-58.0K | $-18.0K | $-41.0K | $-10.0K | $-23.0K | $-4.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $2M | $197.0K | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | $197.0K | · | · | · | |
| Financing Cash Flow | $-233.0K | $605.0K | $34M | $752.0K | $1M | $11M | $329.0K | $-138.0K | $12M | $2M | $-3.0K | $2M | $-10.0K | $5M | $869.0K | $-374.0K | |
| Net Change in Cash | $-6M | $-3M | $28M | $-5M | $-9M | $3M | $-7M | $-6M | $5M | $-3M | $-4M | $-2M | $-3M | $-5M | $839.0K | $-6M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | $-3M | · | · | · |
Rentabilité 7
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | 141020.0% | · | 737250.0% | 196950.0% | 89730.0% | · | 631250.0% | 174471.4% | |
| Net Margin | · | · | · | · | · | · | · | · | 91510.0% | · | 337450.0% | 78766.7% | 61720.0% | · | 331250.0% | 82171.4% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | 78766.7% | 61720.0% | · | · | 83957.1% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | 140750.0% | · | 737250.0% | 196950.0% | 89520.0% | · | 631250.0% | 174471.4% | |
| ROA | -15.3% | · | -13.9% | -24.9% | -27.2% | · | -29.9% | -18.0% | -21.7% | · | -14.6% | -9.8% | -11.8% | · | -19.8% | -21.8% | |
| ROE | -21.7% | · | -19.3% | -44.8% | -41.2% | · | -45.8% | -24.5% | -28.3% | · | -19.8% | -12.1% | -14.6% | · | 28.0% | -26.2% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -27.2% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | · | 6.4 | 1.5 | 2.1 | · | 2.1 | 3.1 | 4.0 | · | 4.4 | 5.3 | 5.7 | · | 4.2 | 7.4 | |
| Quick Ratio | 5.1 | · | 5.9 | 0.9 | 1.5 | · | 1.7 | 2.6 | 3.6 | · | 4.0 | 4.7 | 5.2 | · | 3.8 | 6.7 |
Efficacité 1
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | -0.0 | · | 0.0 | -0.0 | -0.0 | · | -0.0 | -0.0 |
Valorisation (TTM) 10
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $-28.0K | · | $-28.0K | $-28.0K | $-28.0K | · | $-28.0K | $-28.0K | $-28.0K | · | $-20.0K | $-25.0K | $-28.0K | · | · | · | |
| Net Income TTM | $-25M | · | $-30M | $-32M | $-35M | · | $-33M | $-28M | $-27M | · | $-24M | $-23M | $-22M | · | $-19M | $-14M | |
| Market Cap | $68M | · | $119M | $20M | $26M | · | $19M | $67M | $73M | · | $44M | $55M | $58M | · | $46M | $48M | |
| P/E | -2.1 | · | -2.4 | -0.5 | -0.5 | · | -0.5 | -2.0 | -2.1 | · | -1.6 | -2.0 | -2.2 | · | -0.2 | -0.2 | |
| P/S | -2425.3 | · | -4255.8 | -719.2 | -931.8 | · | -683.5 | -2378.1 | -2599.1 | · | -2190.0 | -2217.0 | -2070.3 | · | · | · | |
| P/B | 2.3 | · | 3.3 | 2.9 | 2.1 | · | 1.3 | 2.9 | 2.5 | · | 1.5 | 1.6 | 1.6 | · | 1.2 | 1.1 | |
| P / Tangible Book | 2.3 | · | 3.3 | 2.9 | 2.1 | · | 1.3 | 2.9 | 2.5 | · | 1.5 | 1.6 | 1.6 | · | 1.2 | 1.1 | |
| P / Cash Flow | -12.3 | · | · | · | -2.6 | · | · | · | -10.0 | · | · | · | -21.4 | · | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | · | -21.1 | · | · | · | |
| Earnings Yield | -47.4% | · | -41.5% | -219.3% | -199.5% | · | -196.2% | -50.0% | -47.2% | · | -61.1% | -49.7% | -46.5% | · | -464.7% | -630.8% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Marge d'exploitation % | — | — | 187866.7% | 155539.3% | 3202.5% |
| Résultat net | $-23M | $-34M | $-26M | $-21M | $-12M |
| BPA dilué | $-0.32 | $-0.86 | $-0.86 | $-0.91 | $-3.13 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 3.4 | 2.7 | 3.4 | 6.1 | 7.5 |
| Ratio de liquidité réduite | 2.6 | 2.2 | 2.9 | 5.3 | 7.0 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | — | $-28M | $-16M | $-19M | $-4M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.